Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

BACKGROUND: Multiple myeloma (MM) is a highly heterogeneous disease with enormously variable outcomes. It remains to be a major challenge to conduct a more precise estimation of the survival of MM patients. The existing stratifications attached less importance to the prognostic significance of comor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Shuangshuang, Bi, Lei, Chu, Yuping, Liu, Xiao, Feng, Juan, Xu, Li, Zhang, Tao, Gu, Hongtao, Yang, Lan, Bai, Qingxian, Liang, Rong, Tian, Biao, Gao, Yaya, Tang, Hailong, Gao, Guangxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968003/
https://www.ncbi.nlm.nih.gov/pubmed/35372057
http://dx.doi.org/10.3389/fonc.2022.805702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968003/
https://www.ncbi.nlm.nih.gov/pubmed/35372057
http://dx.doi.org/10.3389/fonc.2022.805702

Ejemplares similares